MedTrace Logo

Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants

NCT00795990 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2014-12-05

No results posted yet for this study

Summary

This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008. The purpose is to compare the outcomes of medical intervention in preterm infants if intervention occurs day of life 4 or less, or day of life 5 or greater, with the birthdate being counted as day of life 1.

Conditions

  • Patent Ductus Arteriosus

Sponsors & Collaborators

Principal Investigators

  • Gary M Chan, MD · University of Utah

Eligibility

Max Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00795990 on ClinicalTrials.gov